Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
agreed.
we have so much good news on the way.
we have the IRB approval news that is about to hit.
we have the hospital study that is about to get underway.
we have more licensing and distribution deals in the works.
this is about to get crazy here.
so many people will be left behind.
February and march will bring staggering gains for this company and for this stock.
OWCP:
OWCP is a very big deal and you are about to find that out.
anybody with just 1/2 a brain and damn near minimal testicular fortitude can make a cool million in this stock.
if you have zero brains and zero testicular fortitude then we will provide that. so you can still make a cool million in this stock.
just accumulate the hell out of this stock and then kick back and relax.
it wont be this cheap for long.
right now no other medical cannabis company has the growth potential that OWCP has.
that is why my money is with OWCP.
and I don't sell a single share. I only think about adding more to my stash.
I firmly believe that we will be sitting at just north of $1 at the close on Friday.
she can move up very rapidly.
float is limited and most of it is locked up.
company is most likely to drop the big hammer after the close today.
or they may do it after the close tomorrow.
but we do know that the big hammer is coming.
and it is going to be awesome news for the OWCP shareholders.
nobody that knows what they are doing will part with a single share.
so that leaves cowards, broke fools, and manipulators.
and who gives a damn about them. you just attack the dips and take advantage of the bargain prices.
we all know exactly where OWCP is going and how it plans to get there.
OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) Closes 2016 On A Higher Note
share on:FacebookTwitter
As 2016 closed in, OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) remained one of the upward trending stocks in the cannabis industry. The company, in the last quarter of 2016, announced signing an agreement with Medmar LLC in a deal that was worth $300,000. Now let us understand what makes OWC Pharmaceutical Research so favoured in the cannabis industry?
The medical research that is worth the partnerships
This company, which is primarily Israeli-based, comes to the U.S. market with much credibility. Israel, for we all know, is among those countries, which offers the best research and clinical trials for cannabis based medicines.
OWC Pharmaceutical Research is a favoured company for partnership due to this ground.
It is believed that the company is reputed for conducting clinical approaches and R&D for medical cannabis in the true sense. The clinical studies conducted by this company have much value in the cannabis market.
To make an investment and partnership with this company comes with its own advantages.
Why everyone wants to befriend OWC Pharmaceutical Research?
Even though the U.S. regulations are difficult to cope with, but there is no denying the fact that the times ahead may be favourable. As of now, any wannabe cannabis company that is looking forward to these times in the U.S. market, need to know that OWC Pharmaceutical Research is definitely in a better position because the environment for cannabis industry in Israel is much more favourable.
This company has continued to ride the higher tide of the cannabis market because it is conducting research in a holistic environment that guarantees clinical research with lesser hurdles.
Who knows what happens in the U.S. next, but for now, there is definitely a hope like a shining moonbeam. The new Presidency era in the U.S. will open up new avenues and hopes for the cannabis industry, which is why, so many companies, which remained dormant as of now, have started picking up the momentum in markets.
great post.
you have to have a firm conviction after you have done a ton of DD.
clearly this stock is headed a lot higher.
this is a real company doing some amazing things that will set it apart in the marketplace.
optimal share structure
not a pink sheet stock
zero toxic debt
best research and development team on the planet
top flight leadership
no shortage of catalysts
zero dilution
very limited float
distribution deals in place to gain rapid global exposure with our products
8 valued patents that Teva tried to buy
it doesn't get any better than this. this is a rare gem and we were lucky to have discovered this company early.
these bargain prices end today.
you can make book on that.
http://www.owcpharma.com/newsroom-photos/
OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) Closes 2016 On A Higher Note
share on:FacebookTwitter
As 2016 closed in, OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) remained one of the upward trending stocks in the cannabis industry. The company, in the last quarter of 2016, announced signing an agreement with Medmar LLC in a deal that was worth $300,000. Now let us understand what makes OWC Pharmaceutical Research so favoured in the cannabis industry?
The medical research that is worth the partnerships
This company, which is primarily Israeli-based, comes to the U.S. market with much credibility. Israel, for we all know, is among those countries, which offers the best research and clinical trials for cannabis based medicines. OWC Pharmaceutical Research is a favoured company for partnership due to this ground.
It is believed that the company is reputed for conducting clinical approaches and R&D for medical cannabis in the true sense. The clinical studies conducted by this company have much value in the cannabis market. To make an investment and partnership with this company comes with its own advantages.
Why everyone wants to befriend OWC Pharmaceutical Research?
Even though the U.S. regulations are difficult to cope with, but there is no denying the fact that the times ahead may be favourable. As of now, any wannabe cannabis company that is looking forward to these times in the U.S. market, need to know that OWC Pharmaceutical Research is definitely in a better position because the environment for cannabis industry in Israel is much more favourable.
This company has continued to ride the higher tide of the cannabis market because it is conducting research in a holistic environment that guarantees clinical research with lesser hurdles. Who knows what happens in the U.S. next, but for now, there is definitely a hope like a shining moonbeam. The new Presidency era in the U.S. will open up new avenues and hopes for the cannabis industry, which is why, so many companies, which remained dormant as of now, have started picking up the momentum in markets.
it will be impossible to keep this down today.
the climb is resumed.
trajectory is north.
she will close in the 70's today.
and we will be at the dollar land soon.
very bloody soon.
exactly right.
this price is one hell of a bargain as people will find out as early as today.
these bargain prices cannot last.
too many good things happening at OWCP.
they manipulate for only one reason: to make their daily bread crumbs.
they steal from the weak.
no worries. this can often put the stock in stronger hands.
dips also give people to load up.
there is zero bad or negative news as far as OWCP is concerned.
in fact they are fixing to drop a very big hammer.
we have nothing but great news on the way.
time to go back up.
let the climb begin to $1.10 to $1.15 at the close on Friday.
this is going to be an awesome week for OWCP and for the OWCP shareholders.
they are just manipulating it to make their daily bread crumbs.
they are stealing shares from the weak.
attack the dips. take advantage of this opportunity.
it wont come again.
it is blatant manipulation with their constant 1000 shares sell orders.
they will have to cover later today.
he is 100% spot on.
this is a dollar level stock that is obviously headed there fast.
it is just deeply undervalued.
next stop is $1.10.
and there is nothing that can be done to stop that.
company has too many catalysts now.
too many irons in the fire.
these bargain prices will end today.
anything under 70 cents is a steal at this point.
attack the dips without mercy as you build your own solid position in this stock.
no way in hell can these prices last.
OWCP:
OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) Closes 2016 On A Higher Note
share on:FacebookTwitter
As 2016 closed in, OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) remained one of the upward trending stocks in the cannabis industry. The company, in the last quarter of 2016, announced signing an agreement with Medmar LLC in a deal that was worth $300,000. Now let us understand what makes OWC Pharmaceutical Research so favoured in the cannabis industry?
The medical research that is worth the partnerships
This company, which is primarily Israeli-based, comes to the U.S. market with much credibility. Israel, for we all know, is among those countries, which offers the best research and clinical trials for cannabis based medicines. OWC Pharmaceutical Research is a favoured company for partnership due to this ground.
It is believed that the company is reputed for conducting clinical approaches and R&D for medical cannabis in the true sense. The clinical studies conducted by this company have much value in the cannabis market. To make an investment and partnership with this company comes with its own advantages.
Why everyone wants to befriend OWC Pharmaceutical Research?
Even though the U.S. regulations are difficult to cope with, but there is no denying the fact that the times ahead may be favourable. As of now, any wannabe cannabis company that is looking forward to these times in the U.S. market, need to know that OWC Pharmaceutical Research is definitely in a better position because the environment for cannabis industry in Israel is much more favourable.
This company has continued to ride the higher tide of the cannabis market because it is conducting research in a holistic environment that guarantees clinical research with lesser hurdles. Who knows what happens in the U.S. next, but for now, there is definitely a hope like a shining moonbeam. The new Presidency era in the U.S. will open up new avenues and hopes for the cannabis industry, which is why, so many companies, which remained dormant as of now, have started picking up the momentum in markets.
I did not say $1 tomorrow.
I said $1.10 or more at the close on Friday.
and I am not Camelot. I am general Clay Death The Destroyer.
memo to OWCP shareholders:
we will start to finalize our plans for Reno this year once OWCP hits $7-$10. and yes OWCP will hit $7 to $10 this year.
everybody that wants to go to Reno to celebrate OWCP's success and to discuss the next big investment opportunity needs to get with Feller and Kraken Taken.
they are going to be the official travel advisors for this trip.
we are also going to make it an annual trip to Reno.
long live OWCP. and long live OWCP shareholders.
OWCP:
OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) Sets the Stage for 2017
By Jermaine Farmer - January 27, 2017
SHARE Facebook Twitter
OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) is a micro-cap medical marijuana play that has some monster gains under its belt over the past few weeks. And traders have certainly taken notice. Management just hit the wires with its annual letter to the Company’s shareholders to further stoke the flames of enthusiasm for this pre-revenue play.
Perhaps most important to note in the letter were the anticipated action items the company would be looking forward to in 2017: 1. During the second quarter of 2017 OWCP intends to initiate its U.S marketing program for its Psoriasis Topical Cream. At the same time, we intend to begin investigating the applicability of topical cream for other skin conditions and disorders. 2. OWCP intends to proceed with the advancement of our cannabis-based treatment for multiple myeloma, with the objective of proceeding with additional studies. And 3. OWCP intends to evaluate the launch of one or more studies to determine the applicability of cannabinoid-based pharmaceuticals for other medical conditions and disorders, such as fibromyalgia and migraines.
OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) bills itself as a company that engages in the research and development of Cannabis-based medical products. The company provides medical products for the treatment of various medical conditions and/or diseases, such as multiple myeloma, psoriasis, PTSD, and migraines; and delivery systems. It also provides consulting services to companies and governmental agencies related to international medical cannabis protocols and regulations.
OWCP through its wholly-owned Israeli subsidiary, One Word Cannabis Ltd., conducts medical research and clinical trials to develop cannabis-based pharmaceuticals, treatments and unique delivery systems for the effective delivery and dosage of medical cannabis.
All OWC research is conducted at leading Israeli hospitals and scientific institutions, and led by internationally renowned investigators.
The Company’s Research Division is focused on pursuing clinical trials evaluating the effectiveness of cannabinoids in the treatment of various medical conditions, while its Consulting Division is dedicated to helping governments and companies navigate complex international cannabis regulatory frameworks.
The Company is a wholly owned subsidiary of OWC Pharmaceutical Research Corp. The company was formerly known as Dynamic Applications Corp. OWC Pharmaceutical Research Corp. was founded in 2008 and is based in Petach Tikva, Israel.
According to company materials, “OWC Pharmaceutical Research Corp., through its wholly-owned Israeli subsidiary, One Word Cannabis Ltd., (collectively “OWC” or the “Company”) conducts medical research and clinical trials to develop cannabis-based pharmaceuticals and treatments for conditions including multiple myeloma, psoriasis, fibromyalgia, PTSD, and migraines. OWC is also developing unique delivery systems for the effective delivery and dosage of medical cannabis. All OWC research is conducted at leading Israeli hospitals and scientific institutions, and led by internationally renowned investigators. The Company’s Research Division is focused on pursuing clinical trials evaluating the effectiveness of cannabinoids for the treatment of various medical conditions, while its Consulting Division is dedicated to helping governments and companies navigate complex international cannabis regulatory frameworks.”
well some of us don't get derailed too easily.
some of us are on a quest. it is impossible for me to get derailed.
I studied OWCP for a year before I decided to invest in this amazing company.
I am a shareholder for life. this is my company.
this is my kind of company.
we have distribution deals in place already to make sure our products get rapid global exposure in the medical cannabis markets.
you have to accumulate the hell out of this stock. this is an opportunity of a lifetime.
http://ownthefloat.com/index.php/2017/01/21/owcp-investor-presentation-for-january/
OWCP:
OWCP is a very big deal. those who don't get that and understand that fast will regret it the rest of their lives.
OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) Closes 2016 On A Higher Note
share on:FacebookTwitter
As 2016 closed in, OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) remained one of the upward trending stocks in the cannabis industry. The company, in the last quarter of 2016, announced signing an agreement with Medmar LLC in a deal that was worth $300,000. Now let us understand what makes OWC Pharmaceutical Research so favoured in the cannabis industry?
The medical research that is worth the partnerships
This company, which is primarily Israeli-based, comes to the U.S. market with much credibility. Israel, for we all know, is among those countries, which offers the best research and clinical trials for cannabis based medicines. OWC Pharmaceutical Research is a favoured company for partnership due to this ground.
It is believed that the company is reputed for conducting clinical approaches and R&D for medical cannabis in the true sense. The clinical studies conducted by this company have much value in the cannabis market. To make an investment and partnership with this company comes with its own advantages.
Why everyone wants to befriend OWC Pharmaceutical Research?
Even though the U.S. regulations are difficult to cope with, but there is no denying the fact that the times ahead may be favourable. As of now, any wannabe cannabis company that is looking forward to these times in the U.S. market, need to know that OWC Pharmaceutical Research is definitely in a better position because the environment for cannabis industry in Israel is much more favourable.
This company has continued to ride the higher tide of the cannabis market because it is conducting research in a holistic environment that guarantees clinical research with lesser hurdles. Who knows what happens in the U.S. next, but for now, there is definitely a hope like a shining moonbeam. The new Presidency era in the U.S. will open up new avenues and hopes for the cannabis industry, which is why, so many companies, which remained dormant as of now, have started picking up the momentum in markets
I am going to be very rich.
I can hardly wait to add more this week like I do every week.
Real wealth in the making.
OWCP is pure excitement.
It is also a road to riches.
Real wealth being made right before people's eyes.
What do you call sub penny to 95 cents clown?
It looks like it is going to gap up.
Big day tomorrow for OWCP and for OWCP shareholders.
We start the journey to the next leg that will take the stock past $1.
I see nothing but green tomorrow.
20 percent 30 percents gains are happening tomorrow even without the news.
But we do know that the company is getting ready to drop the big hammer.
A very big hammer. This one is going to hurt.
Don't get left behind. Accumulate hell out of this stock.
Attack the minor dips. Window will close very quickly tomorrow.
It is too risky to not own a few tons of this stock.
February and march is rocket city.
Stock is getting ready to skyrocket starting tomorrow.
It is going to leave a few people behind.
She is going to move up rapidly.
Just staggering pent up demand now.
People want in and they are going to get in.
These are still bargain prices.
Stock is very seriously undervalued.
I think this is the week we make our move over to the dollar land.
We need a big day tomorrow and then it is on.
All indications are that tomorrow will be huge.
It is fixing to skyrocket.
It said I have a 48 hour wait.
I will try again.